Oscar Investments Limited was incorporated on January 25, 1978 as a public limited Company in Mumbai. Subsequently, registered office of the Company was shifted from Mumbai to NCT of Delhi. The Company is listed on Bombay Stock Exchange (BSE).

  • Mr. Malvinder Mohan Singh,
    (Promoter Non-Executive Director)
  • Mr. Shivinder Mohan Singh,
    (Promoter Non-Executive Director)
  • Dr. Preetinder Singh Joshi,
    (Non-Executive Independent Director)
  • Mr. Varun Sood,
    (Managing Director)
  • Mrs. Aditi Shivinder Singh,
    (Promoter Non-Executive Director)
  • Mr. Ravi Sikka,
    (Non-Executive Independent Director)

Malvinder is a dynamic, young business leader who has made a mark on the global landscape by simultaneously pursuing the twin objectives of business for profit and for public good, in a way that positively impacts lives.
With the intent of providing broad based world class services through transformative business and delivery models, Malvinder is shaping the contours of the healthcare and financial services industries and driving their evolution.
In Healthcare, Malvinder incubated and established Fortis Healthcare Limited, in the late 1990's. Since then, he has been instrumental in transforming it into a leading healthcare delivery company in India and more recently in Asia, as the largest emerging healthcare organisation.
With a vision of making quality healthcare services accessible to all, he continues to assiduously pursue this objective, to make it a reality, using innovative business models.
In the Financial Services and Insurance sectors, Malvinder has business interests through Religare Enterprises. As Chairman of the company till 2010, he evolved Religare's strategy of creating an integrated financial services organization in India and an emerging global asset management platform.
Previously, Malvinder was Chairman, MD and CEO of Ranbaxy Laboratories. He led the expansion of Ranbaxy through a series of strategic partnerships and acquisitions resulting in Ranbaxy becoming a top 10 generic pharmaceutical company, globally. He spearheaded the coming together of Ranbaxy and Daiichi Sankyo, to create the world's fifteenth largest pharmaceutical company – a move seen as a game-changer by industry experts. Malvinder strongly believes in the ability of people to do extraordinary things, in challenging environments. In a precedence setting move, he entrusted the management of Religare to a professional management team by stepping down as Chairman of the company in 2010. He continues to oversee his family's majority interest in Religare, as shareholder.
Malvinder has always supported strategic business decisions in the best interest of the companies he has led and continues to lead. The sale of his personal stake in Ranbaxy to Daiichi Sankyo, to secure longevity and a place for Ranbaxy as a top ranking Global Pharmaceutical Company and his decision to exit investments in Parkway Healthcare, emphatically demonstrated his ability to steer his companies, always keeping the best interests of its stakeholders, in mind.
Malvinder has a strong personal belief in the social responsibility of individuals and corporates. With a focus on affordability and accessibility to life saving medicines in emerging and under developed countries; he channelled resources towards innovation, to reduce the cost of ARV medication and for the development of a new low cost synthetic anti-malarial drug. He keenly supports initiatives to provide curative and preventive healthcare to the under privileged in India's villages and urban slums through various foundations and trusts.
Malvinder is a member of the Board of Visitors at the Fuqua School of Business (Duke University, USA) and the Board of the Indian Council for Research on International Economic Relations (ICRIER). He was a member of the first batch of the Young Global Leaders initiative of the World Economic Forum. A graduate in Economics, he earned his MBA from the Fuqua School of Business, Duke University, USA.

Shivinder Mohan Singh is an entrepreneur who aspires to change the way Healthcare is delivered in the world. He is the Executive Vice Chairman of Fortis Healthcare Limited, a leading, integrated healthcare delivery provider in the Pan Asia-Pacific region. Fortis' healthcare verticals span primary healthcare, speciality day care, diagnostics and hospitals, with an asset base in 10 countries, many of which represent the fastest-growing healthcare delivery markets in the world. Fortis is driven by the vision of becoming a global leader in the integrated healthcare delivery space and the larger purpose of saving and enriching lives through clinical excellence.
Shivinder is also one of the principal promoters of Religare Enterprises Limited, Super Religare Laboratories Limited and Religare Technologies Limited. He was one of the key promoters of global pharma major Ranbaxy Laboratories and a director on its board; playing a strategic role in its sale and in taking the company to the next level, while creating significant long-term value for all stakeholders.
Shivinder has done his MBA with specialisation in health sector management from the Duke University Business School, USA. His significant contribution to Indian Healthcare is widely acknowledged. His strategy for Fortis, and its execution, has been recognised by the Harvard Business School as a case study. For over a decade, Shivinder has led from the front in shaping the private healthcare space in India. He is an alumnus of Doon School and an Honours Graduate in Mathematics from St. Stephens College, Delhi. He has lead various healthcare bodies and state level initiatives for the industry. He is also the Chairman of the Membership Committee of FICCI (Federation of Indian Chambers of Commerce and Industry).
While healthcare is a passion for Shivinder, his dream is to contribute in building a vibrant India. He is involved in a number of initiatives focused on social change - a better future for the girl child, HIV education, quality healthcare in Rural India and more. Shivinder is on the board of visitors of Fuqua School of Business, Duke University, USA and the board of trustees of Aspen India. He is also on the national board of advisors for AIESEC, a global, non-political and independent, not-for-profit organization run by students and graduates from institutions of higher education.
Shivinder lives with his wife Aditi and their four sons, in New Delhi. He likes sports such as football and tennis and enjoys watching films.

Dr. Preetinder Singh Joshi, an eminent Cardiologist, holds an MBBS degree in Medicine from Medical College, Amritsar (Punjab University, Chandigarh 1970) and MD degree in Cardiology & General Medicine from Maulana Azad Medical College (Delhi University 1974). (He stood first in the University and was declared best graduate of Medical College, Amritsar). He became a member of Royal College of Physicians, UK (MRCP) in 1978.
He is a Fellow of American College of Cardiology (FACC), Fellow Royal College of Physicians Edinburgh (FRCP) and Fellow Cardiological Society of India. He has over 40 years of experience in medical profession in India and abroad. He has held many positions of responsibility including Directorship and Head, Department of Medicine & Cardiology Divisions in Escorts Medical Centre (1981-84), Birla Centre for Medical Research, New Delhi (1984-85) & Maharaj Sawan Singh Charitable Hospital, Beas (1985-till date).

Over his career, Varun has worked in the technology, healthcare, pharmaceuticals, consulting, telecom and IT sectors and has deep business experience spanning general management, strategy development, operations, M&A and technology. He has rich global multi-cultural exposure having worked in India, USA and South Africa in Indian and global MNC's.
Previously, Varun was part of the leadership team at Fortis Healthcare Ltd, one of India's largest integrated healthcare delivery service providers with 55 hospitals and 275+ laboratories. As CIO & Head Strategic Initiatives at Fortis Healthcare, Varun successfully spearheaded the integration and transformation of Fortis using technology as a key business driver and a source of competitive advantage. Prior to this, as Vice President Strategic Initiatives he established global shared framework and operations for Fortis across its operations in India, Australia, Hong Kong, Vietnam and Singapore and was responsible for process standardization across Fortis's India operations.
Prior to Fortis, Varun was with Ranbaxy Laboratories Ltd, India's largest pharmaceutical company and #8 global generic pharmaceutical company. Varun drove the global integration of Ranbaxy with Daiichi Sankyo, world's top 10 pharmaceutical company that acquired Ranbaxy in 2008. Prior to that, Varun was responsible for driving integration of companies acquired by Ranbaxy globally. Prior to this, he was responsible for enterprise wide structural and process based business optimization and owned all corporate IT systems at Ranbaxy.
Earlier, Varun was with the Compunnel Software Group based in the US where, among other engagements, he worked with Price Waterhouse Coopers and Verizon.
In the past, he has served on several other boards including Dion Global Solutions Ltd. and various Fortis Healthcare entities. He was the Co-Chair at the Confederation of Indian Industry (CII) CIO Forum from 2013-2016 and part of various healthcare task forces created by CII, FICCI and NatHealth. Varun obtained his Bachelors of Engineering in Electronics & Communications from Manipal Institute of Technology, India.

Mrs. Aditi Shivinder Singh is graduated with a bachelor‘s degree in Science from St. Stephens College, Delhi University and PG Diploma in Brain Development Therapy from Spastic Society of Northern India.

Mr. Ravi Sikka is a Member of The Institute of Chartered Accountants of India since February 1978 and has more three decades of experience in Group Taxation, Secretarial and legal, Management of Company Boards, Corporate HR, Payrolls and Individual taxation including managing the promoters finances and tax portfolios in Eicher Group.
He was responsible for statutory audits for the Group companies apart from heading the Finance, Accounts, Treasury and budgeting / MIS function of the Tractor Business of the Group and has lead major internal restructuring projects for the Eicher Group and as well supported Mergers, Acquisitions and divestiture activities in the Group apart from providing on-going tax management, Company law, Secretarial, Legal and Corporate Governance functions.

  • Shimal Research Laboratories Limited
  • Fortis Clinical research Limited (Step-down Subsidiary Company)
  • Audit Committee
  • Stakeholders Relationship Committee
  • Nomination and Remuneration Committee
  • Risk Management Committee
  • CSR Committee